IRIS
ROSSI, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.164
EU - Europa 10.849
AS - Asia 6.580
SA - Sud America 1.361
Continente sconosciuto - Info sul continente non disponibili 406
AF - Africa 132
OC - Oceania 7
Totale 30.499
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.904
RU - Federazione Russa 2.902
IE - Irlanda 2.607
SG - Singapore 1.792
CN - Cina 1.740
HK - Hong Kong 1.401
DE - Germania 1.351
UA - Ucraina 1.034
BR - Brasile 1.033
SE - Svezia 965
VN - Vietnam 833
FI - Finlandia 603
IT - Italia 492
FR - Francia 400
IN - India 231
GB - Regno Unito 212
AR - Argentina 146
CA - Canada 130
BD - Bangladesh 121
KR - Corea 96
MX - Messico 74
ID - Indonesia 58
ZA - Sudafrica 54
PL - Polonia 50
EC - Ecuador 49
JP - Giappone 48
IQ - Iraq 41
NL - Olanda 40
CO - Colombia 38
EU - Europa 38
IR - Iran 37
TR - Turchia 32
PY - Paraguay 31
VE - Venezuela 30
AT - Austria 29
ES - Italia 29
BE - Belgio 26
CZ - Repubblica Ceca 24
PK - Pakistan 19
LT - Lituania 18
CL - Cile 15
JM - Giamaica 15
MA - Marocco 15
UZ - Uzbekistan 14
PH - Filippine 13
EG - Egitto 12
MD - Moldavia 12
KE - Kenya 11
RO - Romania 10
SA - Arabia Saudita 10
TW - Taiwan 10
CR - Costa Rica 9
IL - Israele 9
MY - Malesia 9
CH - Svizzera 8
DZ - Algeria 8
OM - Oman 7
PE - Perù 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
BG - Bulgaria 6
DK - Danimarca 6
HN - Honduras 6
KZ - Kazakistan 6
TN - Tunisia 6
AU - Australia 5
AZ - Azerbaigian 5
BJ - Benin 5
ET - Etiopia 5
GR - Grecia 5
HR - Croazia 5
KG - Kirghizistan 4
LB - Libano 4
NP - Nepal 4
PA - Panama 4
SN - Senegal 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
AM - Armenia 3
BH - Bahrain 3
CY - Cipro 3
GT - Guatemala 3
MN - Mongolia 3
NI - Nicaragua 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BB - Barbados 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BS - Bahamas 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GY - Guiana 2
JO - Giordania 2
MU - Mauritius 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
Totale 30.112
Salva come PNG Salva come JPEG
Città #
Dublin 2.606
Jacksonville 1.903
Hong Kong 1.400
Dearborn 1.008
San Jose 947
Singapore 725
Wilmington 701
Ashburn 561
Council Bluffs 561
Beijing 509
Moscow 382
Chandler 380
Princeton 340
Lawrence 339
Ho Chi Minh City 292
Lauterbourg 290
San Mateo 256
Los Angeles 237
Hanoi 185
Andover 177
Ann Arbor 167
Buffalo 165
Piemonte 146
Santa Clara 115
Columbus 113
New York 110
São Paulo 101
Boardman 92
Seoul 90
Dallas 81
Hefei 80
Houston 76
Nanjing 72
Redondo Beach 71
Orem 68
Kunming 65
Guangzhou 64
Woodbridge 64
Frankfurt am Main 56
Munich 50
Bremen 47
Norwalk 44
Montreal 41
Tokyo 41
Novara 40
Warsaw 40
Rio de Janeiro 39
Atlanta 38
Toronto 37
Denver 36
Mexico City 36
Tianjin 35
Chennai 34
Helsinki 34
London 34
Da Nang 33
Chicago 32
Grafing 32
Hangzhou 32
Jinan 32
Milan 32
Seattle 32
Düsseldorf 31
Nuremberg 30
Phoenix 28
Haiphong 27
Nanchang 26
Belo Horizonte 25
Poplar 24
Brussels 23
Stockholm 23
Brooklyn 22
Johannesburg 22
Shanghai 22
Fairfield 20
Amsterdam 18
Biên Hòa 18
Guayaquil 18
Las Vegas 18
San Francisco 18
Thái Bình 18
Zanjan 18
Brno 17
Curitiba 17
Manchester 17
Mumbai 17
Ninh Bình 17
Turku 17
Dhaka 16
Fuzhou 16
Boston 15
Shenyang 15
Vercelli 15
Asunción 14
Manaus 14
Zhengzhou 14
Buenos Aires 13
Leawood 13
Paris 13
Porto Alegre 13
Totale 17.168
Salva come PNG Salva come JPEG
Nome #
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia 183
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels 181
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 178
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 176
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 167
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 160
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 154
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 154
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 152
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 149
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. 148
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 147
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 143
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 143
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 142
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 140
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 139
CLINICAL IMPLICATIONS OF THE MOLECULAR GENETICS OF CHRONIC LYMPHOCYTIC LEUKEMIA 139
Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1 139
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials 138
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 138
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 137
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 136
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 136
The clinical implications of gene mutations in chronic lymphocytic leukaemia 136
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 136
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 136
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 135
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 135
Absence of NOTCH1 gene mutations in MALT lymphomas 134
The genetics of nodal marginal zone lymphoma 129
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 128
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 127
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study 127
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders 126
Biology and treatment of Richter syndrome 126
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 126
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 126
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 125
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 125
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 125
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 124
Extra-osseous Ewing sarcoma of the thyroid gland mimicking lymphoma recurrence: a case report 124
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation 124
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 123
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 122
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 122
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 122
ALTERAZIONI GENETICHE E INTERAZIONI CON IL MICROAMBIENTE NEI LINFOMI MALIGNI 121
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia 121
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 121
MYC NETWORK MUTATIONS IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKAEMIA 120
Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients 120
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 120
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 120
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 119
AGGIORNAMENTI DI PATOGENESI MOLECOLARE DEI LINFOMI HIV-CORRELATI 119
GENETIC LESIONS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA CHEMO-REFRACTORINESS 119
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma 118
14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia 118
BCL2 MUTATION SPECTRUM IN B-CELL NON-HODGKIN LYMPHOMAS AND PATTERNS ASSOCIATED WITH EVOLUTION OF FOLLICULAR LYMPHOMA 116
Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia 116
Clues to the pathogenesis of Waldenström Macroglobulinemia and IgM-MGUS provided by the analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors 116
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome 116
Recurrent mutations refine prognosis in chronic lymphocytic leukemia. 115
Simian Virus 40 (SV40) infection in lymphoproliferative disorders: A reappraisal based on five hundred cases 114
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia 110
Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance. 110
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study 110
Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients 110
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation 109
Renal handling of monoclonal free light chains depends on fractional excretion: study on 1039 serum-urine paired samples of 187 patients 108
RICHTER SYNDROME: FROM MOLECULAR GENETIC TO THERAPEUTIC STRATEGIES 108
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia 108
Cryoglobulin-induced IL-1 beta gene expression and procytokine in monocytes from cryoglobulinemic patients. 107
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP 107
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease. 107
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 107
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL 107
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia 106
Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases. 105
Beta-2-microglobulin is an independent predictor of progression in asymptomatic multiple myeloma 105
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukemia 105
Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia 105
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression 105
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations 105
Genetic and phenotypic attributes of splenic marginal zone lymphoma 105
The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment 104
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia 103
ASSOCIATION BETWEEN GENE AND MIRNA EXPRESSION PROFILES AND STEREOTYPED SUBSET #4 B-CELL RECEPTOR IN CHRONIC LYMPHOCYTIC LEUKEMIA. 102
ASPETTI MOLECOLARI DEI LINFOMI ASSOCIATI A HIV 101
GENETIC ABERRATIONS OF SIGNALING PATHWAYS IN LYMPHOMAGENESIS: REVELATIONS FROM NEXT GENERATION SEQUENCING STUDIES 101
Analysis of the coding genome of diffuse large B-cell lymphoma 101
Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome 101
MOLECULAR PATHOPHYSIOLOGY OF INDOLENT LYMPHOMA 99
Hepatitis B virus and lymphomagenesis: novel insights into an occult relationship 99
Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma 99
HLA-G IS A COMPONENT OF THE CLL ESCAPE REPERTOIRE TO GENERATE IMMUNE SUPPRESSION: IMPACT OF HLA-G 14 BP (RS66554220) POLYMORPHISM 99
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi 99
A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS 99
Totale 12.367
Salva come PNG Salva come JPEG
Categoria #
all - tutte 158.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.437
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.935 0 12 284 193 154 15 209 31 154 57 363 463
2022/20234.202 356 132 213 60 154 321 98 177 2.532 5 95 59
2023/20241.217 74 68 82 22 238 15 256 29 5 5 81 342
2024/20253.295 63 10 68 40 93 218 279 246 1.221 418 103 536
2025/202611.064 425 392 1.002 1.744 753 776 1.646 1.916 853 835 558 164
2026/20271.034 424 610 0 0 0 0 0 0 0 0 0 0
Totale 30.499